GeneDx (NASDAQ:WGS) and Kindly MD (NASDAQ:KDLY) Head-To-Head Comparison

GeneDx (NASDAQ:WGS) and Kindly MD (NASDAQ:KDLY) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, valuation, dividends, profitability, analyst recommendations, institutional ownership and risk.

Profitability

This table compares GeneDx and Kindly MD’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
GeneDx	-48.21%	-22.71%	-12.39%
Kindly MD	N/A	N/A	N/A

Analyst Ratings

This is a breakdown of current ratings for GeneDx and Kindly MD, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
GeneDx	0	3	3	0	2.50
Kindly MD	0	0	0	0	N/A

GeneDx presently has a consensus price target of $45.67, suggesting a potential downside of 45.65%. Given GeneDx’s higher probable upside, equities analysts clearly believe GeneDx is more favorable than Kindly MD.

Insider & Institutional Ownership

61.7% of GeneDx shares are owned by institutional investors. 28.1% of GeneDx shares are owned by insiders. Comparatively, 50.5% of Kindly MD shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Earnings and Valuation

This table compares GeneDx and Kindly MD”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
GeneDx	$243.66 million	9.01	-$175.77 million	($5.18)	-16.22
Kindly MD	$3.10 million	1.92	N/A	N/A	N/A

Kindly MD has lower revenue, but higher earnings than GeneDx.

Summary

GeneDx beats Kindly MD on 5 of the 9 factors compared between the two stocks.

About GeneDx

GeneDx Holdings Corp., through its subsidiaries, provides genomics-related diagnostic and information services. The company offers Centrellis, an AI-driven health intelligence platform that integrates digital tools and artificial intelligence allowing scientists to ingest and synthesize clinical and genomic data to deliver comprehensive health insights. It provides genetic diagnostic tests, screening solutions, and information with a focus on pediatrics, rare diseases for children and adults, and hereditary cancer screening. GeneDx Holdings Corp. was founded in 2017 and is headquartered in Stamford, Connecticut.

About Kindly MD

KindlyMD Inc. is a patient-first healthcare and healthcare data company uniquely integrating traditional primary care and pain management strategies with integrated behavioral and alternative therapies, including the recommendation of medical cannabis in patient treatment plans in compliance with a legalized state medical cannabis regulatory scheme. KindlyMD Inc. is based in SALT LAKE CITY, UT.